1 Science Powerhouse To Own for the Next Decade
Thermo Fisher Scientific has a knack for thriving even in challenging markets. While the company isn’t entirely immune to today’s global headwinds, slower biopharmaceutical spending, tighter budgets in academic labs, and muted demand in China, it has weathered the storm far better than most of its peers.
The reason?
A combination of unmatched scale,
» Read more about: 1 Science Powerhouse To Own for the Next Decade »
Read More
What If You’d Invested $2,000 in O’Reilly Automotive in 1993?
Imagine putting $2,000 into a stock and forgetting about it. No fiddling, no panic-selling, no checking your account every day. You look up a few decades later and you discover your modest investment has ballooned into more than $1 million.
That’s not a fantasy. That’s what actually happened if you invested in O’Reilly Automotive (NASDAQ: ORLY) when it went public 32 years ago.
» Read more about: What If You’d Invested $2,000 in O’Reilly Automotive in 1993? »
Read More
Why Stanley Druckenmiller Dumped AI Darling Palantir
Stanley Druckenmiller who famously helped George Soros break the Bank of England in 1992 has just ditched one of Wall Street’s most hyped artificial intelligence (AI) stocks.
So, what did he sell? Palantir Technologies (NYSE: PLTR). While most investors were busy chasing the AI boom, Druckenmiller was building a large position in a drugmaker.
» Read more about: Why Stanley Druckenmiller Dumped AI Darling Palantir »
Read More
Is AMC Entertainment Staging a Monster Comeback?
AMC Entertainment (NYSE: AMC) isn’t exactly the comeback kid just yet, but you might want to keep it on your radar.
Over the past month, shares have quietly climbed 14.96%, a surprising twist for a stock that’s still down more than 39% from last year and worse from its meme stock mania highs,
» Read more about: Is AMC Entertainment Staging a Monster Comeback? »
Read More
Will Buffett’s 23-Quarter Streak Start Again?
For more than half a decade, Warren Buffett’s Berkshire Hathaway accumulated the same stock quarter after quarter, 23 straight times, to be exact. Then, without warning, the buying stopped last year.
It wasn’t because Buffett lost faith in the company. In fact, his recent moves suggest he’s been biding his time, waiting for the numbers and the price to line up again.
» Read more about: Will Buffett’s 23-Quarter Streak Start Again? »
Read MoreThe Burst
UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read MoreThe Spotlight
Is Stellantis a Dividend Gem Hiding in Plain Sight?
Stellantis (NYSE: STLA) probably isn’t the first ticker that comes to mind when investors think “income stock.” But maybe it should be. The global auto giant, which straddles Italy, France, and the U.S. is delivering one of the highest dividend yields on the market today. It’s not just about the headline number, though. There’s a lot going on beneath the surface that most investors overlook—and some of it’s surprising.
» Read more about: Is Stellantis a Dividend Gem Hiding in Plain Sight? »
Read MoreThe Daily
The Fed announces quarter-point interest rate cut. What it means for you
According to preliminary data, the S&P 500 lost 6.63 points, or 0.10%, to end at 6,600.13 points, while the Nasdaq Composite lost 73.10 points, or 0.33%, to 22,260.85. The Dow Jones Industrial Average rose 262.26 points, or 0.56%, to 46,012.75.
– Reuters
During a press conference after the decision,
» Read more about: The Fed announces quarter-point interest rate cut. What it means for you »